Ensure data integrity, accelerate validation cycles and maintain inspection readiness with our end-to-end compliance solutions — CSV, FDA 21 CFR Part 11 and GAMP 5 validation services.
We partner with the world's most innovative life sciences organizations to deliver unparalleled compliance and validation infrastructure. Our footprint spans top-tier pharma, biotech and medical device manufacturers.
Solutions designed to accelerate time-to-market while reducing regulatory risk — for pharma, biotech, medical devices, CROs and laboratories.
Validation strategy and master plans (VMP), GAMP 5 risk assessments, URS/FS/DS/RTM documentation and IQ/OQ/PQ execution for cloud, SaaS, ERP, LIMS and QMS applications.
Risk-based DQ/IQ/OQ/PQ for manufacturing and laboratory assets, including family-grouping strategies and templated protocols that clear backlogs fast.
Quality management system implementation, CAPA and change control harmonisation, eQMS validation and ISO 9001 / 13485 certification support.
ALCOA+ assessments, audit trail and access control reviews, and remediation of shared-credential and orphaned-data findings across GxP systems.
Gap assessments against FDA and EU expectations, warning letter response, 483 remediation programmes and mock inspection support.
Hands-on CSV, CSA and data integrity training for QA and IT teams, so compliance capability stays in-house after we leave.
We bridge the gap between rigorous regulatory compliance and practical operational excellence.
Years of exclusive focus on life sciences. Our consultants speak the FDA's language — 21 CFR Part 11, GAMP 5, ICH — because they've operated in these environments for decades.
We don't just govern systems — we build robust validation frameworks with end-to-end CSV pipelines tailored specifically for pharma.
Delivery capabilities operating dynamically across critical global markets — scalable, real-time insight and execution, not theoretical compliance advice.
Our Center of Excellence combines a deeply regulated technology track record with a purpose-built compliance practice — aligned with ISPE and ICH guidelines.
Most IT consultancies can't speak to FDA inspectors. Most quality consultancies can't fix the systems. Most engineering firms don't understand GxP. DromoMinds does all three.
Discuss Your Compliance StrategyElectronic records, electronic signatures and audit trails.
Computerised systems governance and lifecycle documentation.
Risk-based approach to compliant GxP computerized systems.
Quality risk management implementation and adherence.
Attributable, legible, contemporaneous, original, accurate data.
Quality management standards for pharma and medical devices.
Good clinical and good laboratory practice adherence.
FDA-encouraged Computer Software Assurance transition.
Real-world challenges solved through disciplined execution and regulatory mastery.
Challenge: A top-tier CRO needed a multi-site global LIMS validated across 4 continents within 6 months.
Outcome: Qualification completed 4 weeks ahead of schedule via centralised validation governance — passing 3 simultaneous sponsor audits in the first quarter post-go-live.
Challenge: A sterile injectables manufacturer faced 200+ unqualified critical assets nearing commercial launch.
Outcome: Entire backlog cleared in 90 days using risk-based bulk qualification — zero FDA 483 observations in the subsequent pre-approval inspection.
Challenge: A warning letter issued to an API manufacturer over ALCOA+ failures — shared credentials and orphaned data.
Outcome: Warning letter lifted after 12 months, with a sustainable Data Governance Board ensuring continuous compliance.
Challenge: A global biotech ran fragmented paper-based CAPA and change control across 15 regional workflows.
Outcome: One validated SaaS eQMS, CAPA cycle times down 65%, and document retrieval during inspections cut from hours to seconds.
Deep domain expertise across the entire life sciences spectrum, aligning specific industrial processes with universal compliance mandates.
End-to-end validation for solid dose, biologics and sterile manufacturing facilities worldwide.
Agile compliance frameworks suited for fast-scaling R&D and pilot manufacturing operations.
Rigorous quality systems validation and Software as a Medical Device (SaMD) compliance.
Ensuring unassailable data integrity across global, multi-center clinical trials.
LIMS, ELN and CDS qualification enforcing strict GLP and Part 11 requirements.
Securing cloud platforms and ensuring HIPAA/GDPR alignment for connected health systems.
"Dromominds Solutions transformed our LIMS validation ecosystem, delivering a zero-483 FDA audit outcome within 90 days. True partners in compliance."
Global Head of QA, Apex Clinical
"Their mastery of 21 CFR Part 11 saved us $180k in strategic rework. EU Annex 11 alignment was seamless, enabling efficient global scaling."
VP of Regulatory Compliance, NovaLife Health
"The QMS implementation was flawless. We achieved our ISO certification without a single minor non-conformance. An exceptionally rigorous team."
Operations Director, MediGene
"Dromominds' CSV framework cut our validation lifecycles in half. Their risk-based approach leveraging GAMP 5 is unmatched in the industry."
Director of Digital Transformation, TechPharma
Evaluate your CSV maturity, compliance readiness and data integrity posture in less than 5 minutes.
Status: Moderate Risk · Industry Avg: 67%
Stop over-validating. Start transitioning. The FDA actively encourages Computer Software Assurance (CSA), yet 78% of life science companies remain stuck in rigid, paper-heavy CSV processes. This kit provides the exact framework to modernize your compliance strategy without risking audit findings.
Risk assessment templates and validation strategy, ready to deploy.
In documentation time using the CSA framework.
Regulatory updates and compliance frameworks for life sciences.
Structured Compliance Readiness Assessment with executive-ready output.
Validation cycles accelerated by up to 40% with automated, template-driven methodologies.
A continuous state of compliance — flawless documentation available to health authorities on demand.
Data silos and ALCOA+ breaches eliminated for reliable scientific and manufacturing records.
Quality risks identified and mitigated before they become critical 483 observations.
Navigate FDA, EMA and global agency expectations backed by domain experts.
Quality embedded into everyday workflows — compliance as an enabler, not a hurdle.
Start with a structured Compliance Readiness Assessment — fixed-fee, executive-ready output that uncovers critical vulnerabilities in your system validation and QMS.
Start Your Free CSV Assessment